MAGGI, Paolo

MAGGI, Paolo  

Dipartimento di Salute Mentale e Fisica e Medicina Preventiva  

Mostra records
Risultati 1 - 20 di 403 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autore(i) File
. Cutaneous reactions in HIV-1 positive patients treated with enfuvirtide 1-gen-2004 Filotico, R; Cassano, N; Altobella, A; Epifani, G; Vena, Ga; Maggi, P
. First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006) 1-gen-2007 Carosi, G; Quiros-Roldan, E; Torti, C; Antinori, A; Bevilacqua, M; Bonadonna, Rc; Bonfanti, P; Castagna, A; Cauda, R; d'Arminio-Monforte, A; Di Gregorio, P; Di Perri, G; Esposito, R; Fatuzzo, F; Gervasoni, C; Giannattasio, C; Guaraldi, G; Lazzarin, A; Lo Caputo, S; Maggi, P; Mazzotta, F; Moroni, M; Prestileo, T; Ranieri, R; Rizzardini, G; Russo, R; Galli, M
. Long term non progressors among IVDA: behavioural, clinical and virological aspects 1-gen-1995 Maggi, P; Buccoliero, G; Angarano, G; Pastore, G
. Prevaleat study (Premature Vascular Lesions and Antiretroviral Therapy). A comparative study between patients treated with PI-including regimens vs NNRTI-including regimens 1-gen-2001 Maggi, P; Fiorentino, G; Epifani, G; Lillo, A; Perilli, F; Ladisa, N; Ferraro, S; Gargiulo, M; Chirianni, A; Angarano, G; Regina, G; Pastore, G
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 1-gen-2020 Di Cristo, V; Adorni, F; Maserati, R; Annovazzi Lodi, M; Bruno, G; Maggi, P; Volpe, A; Vitiello, P; Abeli, C; Bonora, S; Ferrara, M; Cossu, Mv; Oreni, Ml; Colella, E; Rusconi, S.
[Acquired immunodeficiency syndrome and pulmonary Mycobacterium xenopi infection. Role of computerized tomography] 1-gen-2000 Viterbo, V; Midiri, M; Stellacci, G; Angelelli, G; Carbonara, S; Maggi, P; Monno, L; Rotondo, Antonio
A case of human brucellosis caused by accidental injection of animal vaccine 1-gen-1990 Squarcione, S; Maggi, P; Lo Caputo, S; De Gennaro, M; Carbonara, S.
A color doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1 positive patients 1-gen-2008 Maggi, P; Chirianni, A; Lillo, A; Perilli, F; Gargiulo, M; Esposito, V; Bellacosa, C; Pastore, G; Regina, G
A color-doppler ultrasonographic comparative study between patients treated with PI-including regimens vs NNRTI-including regimens (Prevaleat study). 1-gen-2004 Maggi, P; Epifani, G; Perilli, F; Lillo, A; Favia, A; Ladisa, N; Chirianni, ; Gargiulo, M; Ferraro, S; Maserati, R; Ravasi, G; Martignoni, A; Grisorio, B; Ferrara, S; Pellegrino, C
A comprehensive development agenda on tenofovir alafenamide in clinical practice 1-gen-2018 Di Biagio, Antonio; Riccardi, Niccolò; Rusconi, Stefano; Guaraldi, Giovanni; Borderi, Marco; De Luca, Andrea; Gianotti, Nicola; Lo Caputo, Sergio; Maggi, Paolo; Maserati, Renato; Maggiolo, Franco
A Cyanobacterium-Like Body found in the stools of an HIV+ patient with diarrhoea 1-gen-1993 Brandonisio, O; Maggi, P; Panaro, Ma; Marangi, A; Marzio, R; Angarano, G.
A greater prevalence of X4 viruses in HIV type 1 intravenous drug users reflects a "CD4+ effect" 1-gen-2011 Monno, L; Scudeller, L; Ladisa, N; Maggi, P; Angarano, G.
A nodular pulmonary lesion due to Linguatula serrata in an HV-positive man 1-gen-2001 Pampiglione, S; Gentile, A; Maggi, P; Scattone, A; Sollitto, F.
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study 1-gen-2005 Torti, C; Quiros-Roldan, E; Regazzi, M; De Luca, A; Mazzotta, F; Antinori, A; Ladisa, N; Micheli, V; Orani, A; Patroni, A; Villani, P; Locaputo, S; Moretti, F; Di Giambenedetto, S; Castelnuovo, F; Maggi, P; Tinelli, C; Carosi, G.
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naïve HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 1-gen-2012 Albini, L; Cesana, Bm; Motta, D; Focà, E; Gotti, D; Calabresi, A; Izzo, I; Bellagamba, R; Fezza, R; Narciso, P; Sighinolfi, L; Maggi, P; Quiros-Roldan, E; Manili, L; Guaraldi, G; Lapadula, G; Torti, C
A retrospective study on non transfusional HCV hepatitis in hemodialized patients 1-gen-1990 Maggi, P; Vulpio, F; Cataldi, G et al
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 1-gen-2022 Scotto, Riccardo; Lanzardo, Amedeo; Buonomo, Antonio Riccardo; Pinchera, Biagio; Cattaneo, Letizia; Sardanelli, Alessia; Mercinelli, Simona; Viceconte, Giulio; Perrella, Alessandro; Esposito, Vincenzo; Codella, Alessio Vinicio; Maggi, Paolo; Zappulo, Emanuela; Villari, Riccardo; Foggia, Maria; Gentile, Ivan; Federico Ii Covid-Team, Null
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 1-gen-2019 Martini, S.; Maggi, P.; Russo, A.; Cascone, A.; Coppola, N.
Abnormalities of abdominal wall: a case of venous displasia between external mammary common femoral veins and right iliac axis with varicocele 1-gen-1995 Fullone, M; Zupo, V; Testini, M; Franchini, G; Simone, M; Maggi, P; Regina, G.
Accettabilità del condom: studio su una coorte di tossicodipendenti e loro partners 1-gen-1994 Maggi, P; Buccoliero, G; Federico, M; Congedo, P; Angarano, G; Pastore, G